ARCHIVES

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

BRCA2 Carriers Reduced BC Risk By Prophylactic Surgery

June 30, 2006

New Treatment Approach To Treating Brain Tumor

April 26, 2002

Guest Editorial: A Near-Term Solution: NCI And COG Agree on Plan to Maintain Enrollment

May 23, 2014

Reports of SPOREs cut Premature, Broder Says, Wait for Peer Review

March 13, 1992

ACCC To Ask Congress To Earmark Appropriations For Construction Of Community Cancer Centers

January 17, 1975

Foon To Direct Barrett Center; Hundahl Leads Commission

March 5, 1999